Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

93results about How to "Efficient and stable expression" patented technology

Pig ROSA26 specific integration site and application thereof

The invention discloses a pig ROSA26 specific integration site and an application thereof. The nucleotide sequence of the site is represented by SEQ ID NO.2. A targeting vector derived from the site is represented by SEQ ID NO.1. The ROSA26 specific site adopted by the invention is not subjected to immune-mediated exclusion and epigenetic modification in genomes of pigs or higher mammals. The site can mediate stable and efficient expression of exogenous genes. With the ROSA26 specific site targeting vector, targeting can be realized with high efficiency.
Owner:NORTHEAST AGRICULTURAL UNIVERSITY

Method for expressing pseudoplectania nigrella mature peptide in recombinant pichia pastoris

The invention provides a method for expressing and producing pseudoplectania nigrella mature peptide recombinant proteins in pichia pastoris cells in a constitutive type mode, which comprises the following steps of: 1) optimizing pseudoplectania nigrella mature peptide genes; 2) obtaining pichia pastoris glyceraldehyde-3-phosphate dehydrogenase promoter DNA sequences by adopting methods such as molecular cloning and the like, and placing the pseudoplectania nigrella mature peptide genes under the regulation and control of the glyceraldehyde-3-phosphate dehydrogenase promoters to connect with plasmids to obtain new, constitutive and secretory type pichia pastoris efficient expression vectors; 3) converting the pichia pastoris by using the vectors and obtaining the recombinant pichia pastoris strains to obtain the pseudoplectania nigrella mature peptide with bioactivity; and 4) optimizing the high-density fermentation conditions of the engineering strains and the expression and purification of the recombinant protein. The pseudoplectania nigrella mature peptide prepared by the method can be applied in the fields of medicinal treatment, food, feed, scientific research and the like and is suitable for the scale production of pseudoplectania nigrella protein.
Owner:刘德虎

Encoding mutation EPSPS (5-enolpyruvyl-shikimate-3-phosphate synthase) gene, and expression vector, expression product and application of encoding mutation EPSPS gene

The invention relates to a novel EPSPS (5-enolpyruvyl-shikimate-3-phosphate synthase) gene, an expression product of the EPSPS gene, a herbicide-resistant gene CTP2-EPSPS (chloroplast transit peptide 2-EPSPS), an expression product and an expression vector of the herbicide-resistant gene CTP2-EPSPS and application of the expression product and the expression vector of the herbicide-resistant gene CTP2-EPSPS. Nucleotide sequences of the EPSPS gene are shown as SEQ ID No.2, amino acid sequences of encoding proteins of the expression product of the EPSPS gene are shown as SEQ ID No.3, the herbicide-resistant gene CTP2-EPSPS contains chloroplast transit peptide CTP2 and the EPSPS gene, nucleotide sequences of the herbicide-resistant gene CTP2-EPSPS are shown as SEQ ID No.5, and the expression product and the expression vector of the herbicide-resistant gene CTP2-EPSPS can be applied to cultivating glyphosate-resistant transgenic corn. The EPSPS gene, the expression product of the EPSPS gene, the herbicide-resistant gene CTP2-EPSPS, the expression product and the application vector of the herbicide-resistant gene CTP2-EPSPS and the application have the advantages that the herbicide-resistant gene can be stably expressed in crop and is high in expression amount, good herbicide-resistant effects can be realized, the corn or other plants can be transited, accordingly, herbicide-resistant characteristics of plants such as the corn can be improved, and an effective way can be provided for improving the herbicide-resistant characteristics of the plants such as the corn during production.
Owner:HENAN ACAD OF AGRI SCI

Modified pig alpha-interferon genes, construction of expression vector and preparation of protein thereof

The invention discloses construction of modified porcine alpha-interferon gene and an expression vector as well as a method for making protein of the modified porcine alpha-interferon gene. A sequence table of the modified porcine alpha-interferon gene is shown in SEQ ID NO.1. The invention discloses a method for making the protein of the modified porcine alpha-interferon gene at the same time, relating to the steps of reformation of the porcine alpha-interferon codon, clone of the gene and high expression in pichia, in particular to improvements on operation methods relevant to matching and reformation of yeast codon preferendum by porcine alpha-interferon codon; a culture method for effectively producing porcine alpha-interferon; measures for preventing pollution; the control of determining quantity and the time of adding methanol and the time of protein expression, namely protein harvest time; asepsis examination; the test of protein content and activity, and a method for enlarging culture condition. The method is easy to operate with low cost, thereby realizing the stable and effective expression of the porcine alpha-interferon in pichia, and improving as much as 300 times of an antiviral activity of the interferon.
Owner:SOUTH CHINA AGRI UNIV +1

Interference RNA miniplasmid of hypoxia induction factor

The invention discloses a low oxygen induction factor low interruption RNA SiRNA-HIF-1 alpha particle. The particle could be high efficiently expressed in cell and could strongly restrict the expression of independent gene in mammal cell.
Owner:RENJI HOSPITAL ATTACHED TO SHANGHAI NO 2 MEDICALUNIV

Method for synthesizing rebaudioside-A through high-density fermentation

The invention discloses a method for synthesizing rebaudioside-A through high-density fermentation. The method comprises the steps that firstly, genes encoded with a cell wall synthetase system is knocked out, and fermentation synthesis of the rebaudioside-A is achieved while the permeability of a cell wall is improved; secondly, thalluses obtained through fermentation are applied to a whole-cellcatalysis reaction, and the high recovery ratio of the rebaudioside-A is achieved; in the high-density fermentation process, when the thalluses grow to the amount of (10-25) g / L (DCW), a culture medium is subjected to fed-batch in a mode of constant dissolved oxygen index feeding, and when cells grow to the stable phase, the density OD<600> of the thalluses reaches to 100-150; the thalluses grow to the stable phase, the culture medium is subjected to fed-batch in a mode of constant speed feeding, and the content of the rebaudioside-A in fermentation liquid after fermentation is completed is 13.7+ / -1.6 g / L; and the thalluses collected in fermentation are subjected to buffer cleaning treatment by using potassium phosphate and then used for a 50 L whole-cell catalysis reaction, and the concentration of the rebaudioside-A in the system is 28.2+ / -4.9 g / L. According to the method, the problem that the conversion rate of stevioside in cell fermentation is low is solved well, operation is easy, production is easy to enlarge, and the good rebaudioside-A preparing prospects are achieved.
Owner:XINGHUA GL STEVIA CO LTD +1

Construction method and application of rolling-circle replication recombinant vector for heterologous protein expression

The invention belongs to the field of biotechnology and botany, and particularly provides a construction method of a rolling-circle replication recombinant vector for heterologous protein expression,the recombinant vector and an application of the recombinant vector. According to the construction method provided by the invention, the high-efficiency rolling-circle replication transient expressionvector mainly based on the sequence of a sweet potato leaf curl virus (SPLCV) is constructed, so that duration time and expression abundance of heterologous nucleic acids and proteins on plants are remarkably improved, and the results of the vector have high repeatability and reliability. The recombinant vector provided by the invention has a molecular tool vector which has an extremely long expression time to heterologous proteins (longer than 20 day compared with the expression time of a common transient expression T vector) and has an extremely high expression abundance (larger than 30-fold expression compared with a common transient expression T vector), and the recombinant vector endows different plants (tobaccos, sweet potatoes and morning glory) with heterologous protein expressioncapability, and makes up the blank of related plants for utilizing transient expression to study gene functions.
Owner:XUZHOU NORMAL UNIVERSITY

Method of establishing hepatitis B virus infection cell model by using porcine primary hepatocyte and hNTCP recombinant lentivirus

The invention discloses a method of establishing a hepatitis B virus infection cell model by using porcine primary hepatocyte and hNTCP recombinant lentivirus and belongs to the technical field of cell modification. The method comprises the following steps: S1, preparing an hNTCP recombinant lentivirus concentrated liquid; S2, preparing liver tissues which are fully digested; S3, preparing the porcine primary hepatocyte; S4, preparing a porcine primary hepatocyte single cell suspension; S5, preparing a cell suspension for paving a plate; S6, paving cell plate and culturing; S7, carrying out hNTCP recombinant lentivirus infection on the porcine primary hepatocyte; and S8, establishing the hepatitis B virus infection cell model. According to the invention, the recombinant lentivirus containing an hNTCP gene is constructed in vitro, the hNTCP gene is integrated into the primary hepatocyte genome through the lentivirus with high efficiency of infection to achieve stable overexpression of hNTCP, so that the primary hepatocyte supports hepatitis B virus infection.
Owner:立沃生物科技(深圳)有限公司

Modified dog alpha1-interferon gene, construction method of expression vector and preparation method of protein encoded by modified dog alpha1-interferon gene

InactiveCN104894139AImprove antiviral activityGood therapeutic effectFungiFermentationMolecular biologyInterferon
The invention discloses a modified dog alpha1-interferon gene and a preparation method of dog alpha1-interferon. The modified dog alpha1-interferon gene has the nucleotide sequence as shown in SEQ ID NO.1 and the amino acid sequence coded by the gene is shown in SEQ ID NO.2. The invention concretely relates to matching and modification for the predilection of a dog alpha1-interferon codon to a yeast codon as well as optimal control on a culture method for efficiently producing dog alpha1-interferon, pollution avoiding measures and operation methods of methanol adding amount and time determination, protein expression time control, namely protein harvest time, sterility test, protein content and activity measurement, culture condition expansion and the like. The method disclosed by the invention is simple and easy to realize, relatively low in cost, and capable of realizing stable and efficient expression of the dog alpha1-interferon in pichia pastoris, and the expressed dog alpha1-interferon has a remarkable effect on treating dog viral infectious diseases and can enhance the immune effect of a rabies vaccine.
Owner:SOUTH CHINA AGRI UNIV

Transposase for efficiently mediating exogenous gene integration, and use thereof

ActiveCN105481984AEfficient Guided AggregationIntegration mediationGenetic material ingredientsTransferasesTransposaseTransposon integration
The invention belongs to the field of molecular biology, and relates to a transposase for efficiently mediating exogenous gene integration, and a use thereof. The transposase is a fusion protein, and fuses a human c-myc pyrenoid positioning signal, and the human c-myc pyrenoid positioning signal can effectively guide aggregation of the transposase in a nucleus. The transposase is loaded in a transposon integration system, can mediate efficient integration of the exogenous gene in host cells, and can efficiently and stably express.
Owner:SHANGHAI CELL THERAPY RES INST +2

Liver cancer tissue specific RNA (Ribose Nucleic Acid) interference system, as well as construction method and application method thereof

The invention provides a liver cancer tissue specific RNA (Ribose Nucleic Acid) interference system, as well as a construction method and an application method thereof. The liver cancer tissue specific RNA interference system comprises an AFP (Alpha Fetal Protein)-Cre vector and an LoxP-shRNA vector which are both constructed by lentiviral vectors, wherein the AFP-Cre vector contains an AFP promoter and a Cre recombinase gene placed at the downstream of the AFP promoter; the LoxP-shRNA vector contains a reconstructive H6 promoter and an shRNA sequence placed at the downstream of the U6 promoter; the reconstructive U6 promoter contained in the LoxP-shRNA vector is the U6 promoter in which a structure, capable of indicating whether the AFP-Cre / LoxP-shRNA system is in work, is inserted inside; and the structure, capable for indicating whether the AFP-Cre / LoxP-shRNA system is in work, is shown as LoxP-CMV-eGFP-LoxP. The RNA interference system, provided by the invention, has the characteristics of being high in liver cancer tissue specificity, long-lasting in effect, high in efficiency, excellent in indication performance, and simple and convenient in operation; and the liver cancer tissue specific RNA interference system enables the liver cancer RNA interferential targeted treatment of liver cancer, provides high convenience to relative research and analysis, and can be widely applied to the treatment of the liver cancer and the basic research.
Owner:ZHONGSHAN HOSPITAL FUDAN UNIV

Recombination expression and application of shrimp antimicrobial peptide genes in probiotic bacteria

The invention provides a recombinant expression of shrimp antibacterial peptide in probiotic bacteria and an application thereof, which comprises the clone of a shrimp antibacterial peptide gene, the construction of the recombinant carrier of the shrimp antibacterial peptide gene, the conversion and the screening of the recombinant carrier of the shrimp antibacterial peptide gene, the engineering bacteria of the fermentation culture expressed antibacterial peptide, and the verification and the purification of an expression product. The invention also provides the application of recombining probiotic bacteria with the shrimp antibacterial peptide gene. The probiotic bacteria which is used for aquaculture feed, in particular to feed chiefly used for shrimps. The recombinant probiotic bacteria can continually propagate in an organism body, is expressed continually within a certain period, is provided for the antibacterial peptide of the organism body, and has good specificity and validity.
Owner:上海汉德食品有限公司

Recombinant human interleukin 15 long peptide fragment and production method thereof

The invention discloses a recombinant human interleukin (IL) 15 long peptide fragment and a production method thereof. The production method comprises the following steps: obtaining a human IL-15 long peptide fragment gene; establishing an eukaryotic expression vector and transforming the vector into Pichia pastoris X-33; performing resistance screening on high-level secretory-expressed yeast transformants; performing induced expression, purifying the supernate through a nickel column and an ion exchange column to obtain rhIL-15L. The production method is characterized in that the amino acid residue Ala of the site Kex2P1' of the vector pPICZAlphaA is mutated into Pro and the Pichia pastoris X-33 is taken as host bacteria, and therefore, mass high-efficiency stable expression of the rhIL-15L is realized; the recombinant protein rhIL-15L produced by the method is marked with HIS and C-MYC tags and prone to protein purification and detection; besides, the recombinant protein rhIL-15L is a glycoprotein which is modified through glycosylation to a certain extent, and therefore, the recombinant protein rhIL-15L has excellent bioactivity and is capable of effectively maintaining the proliferation and the bioactivity of human NK (Natural killer) cells in vitro and of a mouse in vivo.
Owner:GUANGZHOU INST OF BIOMEDICINE & HEALTH CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products